$307.800,00
10% de descuento pagando con Transferencia
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

Immunomodulators Part B brings together a curated set of research-focused chapters that explore how the immune system is influenced by microbes, immune checkpoint molecules, genetic regulation, and emerging therapeutic strategies. It covers the role of the microbiome and microbial products in shaping immune responses relevant to gastrointestinal cancers, examines VISTA as a “double-edged” checkpoint in cancer and autoimmunity, and uses bioinformatics to uncover immune-modulatory patterns in HPV-associated head and neck squamous cell carcinoma and bladder cancer.

  • Explores how gut microbiota and their metabolites influence immune responses
  • Focuses specifically on gastrointestinal cancer immunology
  • Connects checkpoint biology to both therapeutic potential and safety/side effects

1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Contributors - p. xi 7. Chapter One: Microbiome and microbial products as immunomodulators: Implications for gastrointestinal cancers - p. 1 8. Chapter Two: VISTA as a Double-Edged immune checkpoint molecule in cancer and autoimmunity - p. 37 9. Chapter Three: Investigating the immune-modulatory association of miRNAs in HPV-associated HNSCC individuals: A bioinformatics approach - p. 55 10. Chapter Four: Transcriptomic insights into epigenetic and immunomodulatory roles of nuclear histone genes in bladder cancer: A bioinformatics approach - p. 77 11. Chapter Five: Identification of common hub genes and pathways in systemic lupus erythematosus and cervical cancer using bioinformatics approach - p. 103 12. Chapter Six: Transcriptomic profiling reveals immune pathway dysregulation and key interferon-responsive genes in Systemic Lupus Erythematosus - p. 123 13. Chapter Seven: Peptides and peptidomimetics as immunomodulator agents targeting neglected tropical diseases - p. 141 14. Chapter Eight: Aptamers as immunomodulatory therapeutic alternatives targeting neglected tropical diseases (NTDs) - p. 191

Descripcion
Descripción

Immunomodulators Part B brings together a curated set of research-focused chapters that explore how the immune system is influenced by microbes, immune checkpoint molecules, genetic regulation, and emerging therapeutic strategies. It covers the role of the microbiome and microbial products in shaping immune responses relevant to gastrointestinal cancers, examines VISTA as a “double-edged” checkpoint in cancer and autoimmunity, and uses bioinformatics to uncover immune-modulatory patterns in HPV-associated head and neck squamous cell carcinoma and bladder cancer.

  • Explores how gut microbiota and their metabolites influence immune responses
  • Focuses specifically on gastrointestinal cancer immunology
  • Connects checkpoint biology to both therapeutic potential and safety/side effects

1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Contributors - p. xi 7. Chapter One: Microbiome and microbial products as immunomodulators: Implications for gastrointestinal cancers - p. 1 8. Chapter Two: VISTA as a Double-Edged immune checkpoint molecule in cancer and autoimmunity - p. 37 9. Chapter Three: Investigating the immune-modulatory association of miRNAs in HPV-associated HNSCC individuals: A bioinformatics approach - p. 55 10. Chapter Four: Transcriptomic insights into epigenetic and immunomodulatory roles of nuclear histone genes in bladder cancer: A bioinformatics approach - p. 77 11. Chapter Five: Identification of common hub genes and pathways in systemic lupus erythematosus and cervical cancer using bioinformatics approach - p. 103 12. Chapter Six: Transcriptomic profiling reveals immune pathway dysregulation and key interferon-responsive genes in Systemic Lupus Erythematosus - p. 123 13. Chapter Seven: Peptides and peptidomimetics as immunomodulator agents targeting neglected tropical diseases - p. 141 14. Chapter Eight: Aptamers as immunomodulatory therapeutic alternatives targeting neglected tropical diseases (NTDs) - p. 191

Indice
Autores
Muestra
Ficha Técnica